Aspen Neuroscience is a San Diego-based biotechnology company headed by Damian McDevitt, President and CEO. The second product in their pipeline is a gene-corrected autologous neuron replacement therapy for genetic variants that increase the risk of Parkinson’s disease (ANPD002).